9:22 AM
Leo Group India
| ||
| Arena's Diet Pill May Spur Renewed Race From Drugmakers Businessweek Arena Pharmaceuticals Inc. (ARNA)'s weight- loss pill, the first cleared in the U.S. in 13 years, and an expected rival are potential breakthroughs in the treatment of obesity that may spur major drugmakers into the market. See all stories on this topic » | ||
| US regulator clears first new weight-loss pill in 13 years NDTV The Food and Drug Administration has approved Arena Pharmaceutical's anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade. Despite only achieving modest weight loss in clinical ... See all stories on this topic » | ||
| ||
| US FDA approves first obesity drug in 13 years Hindu Business Line The FDA said it would require Arena Pharmaceuticals - which has offices in San Diego, California and Zofingen, Switzerland - to conduct six future post-marketing studies to assess risks such as heart attack and stroke. The label will also recommend ... See all stories on this topic » | ||
| 2012 Pharmaceutical Diversification Trends, Egypt & Saudi Arabia ... MarketWatch (press release) Pharmaceutical companies are facing unprecedented pressures including revenue loss due to the patent cliff and growing healthcare cost containment measures introduced in most developed markets. As a result, they have been forced to reassess their ... See all stories on this topic » | ||
| TEXT-Fitch rates Watson Pharmaceuticals Reuters June 27 - Fitch Ratings has assigned a 'BBB' rating to WatsonPharmaceuticals, Inc.'s (Watson) (NYSE: WPI) new five-year seniorunsecured term loan facility with an aggregate principal amount of $1.8 billion.Watson's. See all stories on this topic » | ||
| FDA OKs first obesity drug in 13 years Chicago Tribune NEW YORK/WASHINGTON (Reuters) - U.S. health regulators approved the first new weight-loss drug in 13 years, allowing Arena Pharmaceuticals Inc to bring its Belviq pill to market as public health advocates push for new solutions to the nation's growing ... See all stories on this topic » | ||
| Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ ... Sacramento Bee PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BELVIQ (pronounced BEL-VEEK) as an adjunct to a reduced-calorie diet and increased physical ... See all stories on this topic » | ||
|
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment